News + Filings Holdings
|
|
5AM Venture Management, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Enliven Therapeutics, Inc.
| ELVN | Common | 5,798,475 | 5,798,475 | 118,346,875,000 | 118,346,875,000 | 29.48 | 14.10 |
Hist
| 06/30/2023 |
|
Entrada Therapeutics, Inc.
| TRDA | Common | 4,408,379 | 0 | 66,742,858,000 | 7,141,574,000 | 16.63 | 13.28 |
Hist
| 06/30/2023 |
|
Disc Medicine, Inc.
| IRON | Common | 488,442 | -100,000 | 21,686,825,000 | 9,982,714,000 | 5.40 | 2.47 |
Hist
| 06/30/2023 |
|
Rallybio Corp
| RLYB | Common | 3,630,724 | -100,000 | 20,549,898,000 | -3,960,959,000 | 5.12 | 9.62 |
Hist
| 06/30/2023 |
|
Vor Biopharma Inc.
| VOR | Common | 6,361,723 | 0 | 19,657,724,000 | -22,647,734,000 | 4.90 | 9.50 |
Hist
| 06/30/2023 |
|
MoonLake Immunotherapeutics
| MLTX | Common | 357,486 | 357,486 | 18,231,786,000 | 18,231,786,000 | 4.54 | 0.68 |
Hist
| 06/30/2023 |
|
Crinetics Pharmaceuticals, Inc.
| CRNX | Common | 862,286 | 0 | 15,538,394,000 | -241,440,000 | 3.87 | 1.60 |
Hist
| 06/30/2023 |
|
Zentalis Pharmaceuticals, Inc.
| ZNTL | Common | 490,000 | 490,000 | 13,822,900,000 | 13,822,900,000 | 3.44 | 0.82 |
Hist
| 06/30/2023 |
|
scPharmaceuticals Inc.
| SCPH | Common | 1,200,647 | -1,534,205 | 12,234,593,000 | -7,374,296,000 | 3.05 | 3.36 |
Hist
| 06/30/2023 |
|
Celldex Therapeutics, Inc.
| CLDX | COMMON | 310,270 | 310,270 | 10,527,461,000 | 10,527,461,000 | 2.62 | |
Hist
| 06/30/2023 |
|
Viking Therapeutics, Inc.
| VKTX | COM | 585,000 | 585,000 | 9,482,850,000 | 9,482,850,000 | 2.36 | |
Hist
| 06/30/2023 |
|
Cogent Biosciences, Inc.
| COGT | Common | 790,440 | 0 | 9,358,810,000 | 221,324,000 | 2.33 | 1.11 |
Hist
| 06/30/2023 |
|
Pharvaris N.V.
| PHVS | Common | 587,600 | 0 | 8,896,264,000 | 2,285,764,000 | 2.22 | 1.74 |
Hist
| 06/30/2023 |
|
Arvinas, Inc.
| ARVN | Common | 320,000 | 0 | 7,942,400,000 | -3,004,800,000 | 1.98 | |
Hist
| 06/30/2023 |
|
Avidity Biosciences, Inc.
| RNA | Common | 665,555 | 0 | 7,381,005,000 | -7,387,660,000 | 1.84 | 0.94 |
Hist
| 06/30/2023 |
|
ANAPTYSBIO, INC
| ANAB | Common | 357,733 | 0 | 7,276,289,000 | -3,809,857,000 | 1.81 | 1.35 |
Hist
| 06/30/2023 |
|
Mirati Therapeutics, Inc.
| MRTX | COM | 192,500 | 192,500 | 6,955,025,000 | 6,955,025,000 | 1.73 | 0.33 |
Hist
| 06/30/2023 |
|
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 280,000 | -20,000 | 6,661,200,000 | -2,101,800,000 | 1.66 | 0.65 |
Hist
| 06/30/2023 |
|
SPRUCE BIOSCIENCES, INC.
| SPRB | Common | 2,364,000 | 2,364,000 | 5,082,600,000 | 5,082,600,000 | 1.27 | 5.95 |
Hist
| 06/30/2023 |
|
Mersana Therapeutics, Inc.
| MRSN | Common | 1,305,000 | 1,305,000 | 4,293,450,000 | 4,293,450,000 | 1.07 | 1.14 |
Hist
| 06/30/2023 |
|
Homology Medicines, Inc.
| FIXX | Common | 4,535,919 | 0 | 4,014,288,000 | -1,700,970,000 | 1.00 | 7.85 |
Hist
| 06/30/2023 |
|
IMPEL PHARMACEUTICALS INC
| IMPL | Common | 2,884,791 | 0 | 3,663,685,000 | -7,154,281,000 | 0.91 | 12.15 |
Hist
| 06/30/2023 |
|
GH Research PLC
| GHRS | Common | 152,022 | 152,022 | 1,803,741,000 | 1,803,741,000 | 0.45 | 0.29 |
Hist
| 06/30/2023 |
|
Cidara Therapeutics, Inc.
| CDTX | COM | 1,134,511 | 0 | 1,281,997,000 | 423,966,000 | 0.32 | 1.26 |
Hist
| 06/30/2023 |
|
Pear Therapeutics, Inc.
| PEAR | Common | 0 | -16,744,113 | 0 | -19,758,053,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
CinCor Pharma, Inc.
| CINC | Common | 0 | -4,937,646 | 0 | -60,683,669,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
IDEAYA Biosciences, Inc.
| IDYA | Common | 0 | -1,196,298 | 0 | -21,736,735,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
Janux Therapeutics, Inc.
| JANX | Common | 0 | -446,266 | 0 | -5,877,323,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
IVERIC bio, Inc.
| ISEE | COM | 0 | -384,626 | 0 | -8,234,843,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
FIBROGEN INC
| FGEN | COM | 0 | -225,583 | 0 | -3,613,840,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|